Zurück zu Projekte

12040.1;5 PFLS-LS

Method comparability as prerequisite for biomarker selection - feasibility study

Zusammenfassung

Method comparability as prerequisite for biomarker selection - feasibility study

Weitere Texte

Abstract

Together FHNW and ProteoMediX will translate verified research results to a clinically applicable diagnostic prototype test for the more accurate detection of prostate cancer addressing a clear unmet medical need. The final test will be based on a unique signature of protein analytes. This proposal comprises a feasibility study using an innovative biosensor-based approach to bridge the gap between mass spectrometrybased verification and immunoassay-based validation of promising diagnostic markers selected from a bundle of candidates, i.e. protein analytes. This feasibility study is key for entering full development aimed at bringing out ProteoMediX¿s first promising product with prognosticated peak sales of 20 million CHF per year.

Beteiligte

Daniel Gygax

Kontaktperson

daniel.gygax@fhnw.ch

Fachhochschule Nordwestschweiz Daniel Gygax Gründenstrasse 40 Hochschule für Life Sciences 4132 Muttenz BL CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2011-01-31
Enddatum
2012-09-16
Bewilligte Gesamtkosten
CHF 92057.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%